Treatment abandonment in children with Wilms tumor at a national referral hospital in Uganda.


Journal

Pediatric surgery international
ISSN: 1437-9813
Titre abrégé: Pediatr Surg Int
Pays: Germany
ID NLM: 8609169

Informations de publication

Date de publication:
27 Jun 2024
Historique:
accepted: 12 06 2024
medline: 27 6 2024
pubmed: 27 6 2024
entrez: 26 6 2024
Statut: epublish

Résumé

The incidence of pediatric Wilms' tumor (WT) is high in Africa, though patients abandon treatment after initial diagnosis. We sought to identify factors associated with WT treatment abandonment in Uganda. A cohort study of patients < 18 years with WT in a Ugandan national referral hospital examined clinical and treatment outcomes data, comparing children whose families adhered to and abandoned treatment. Abandonment was defined as the inability to complete neoadjuvant chemotherapy and surgery for patients with unilateral WT and definitive chemotherapy for patients with bilateral WT. Patient factors were assessed via bivariate logistic regression. 137 WT patients were included from 2012 to 2017. The mean age was 3.9 years, 71% (n = 98) were stage III or higher. After diagnosis, 86% (n = 118) started neoadjuvant chemotherapy, 59% (n = 82) completed neoadjuvant therapy, and 55% (n = 75) adhered to treatment through surgery. Treatment abandonment was associated with poor chemotherapy response (odds ratio [OR] 4.70, 95% confidence interval [CI] 1.30-17.0) and tumor size > 25 cm (OR 2.67, 95% CI 1.05-6.81). Children with WT in Uganda frequently abandon care during neoadjuvant therapy, particularly those with large tumors with poor response. Further investigation into the factors that influence treatment abandonment and a deeper understanding of tumor biology are needed to improve treatment adherence of children with WT in Uganda.

Identifiants

pubmed: 38926234
doi: 10.1007/s00383-024-05744-7
pii: 10.1007/s00383-024-05744-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

162

Informations de copyright

© 2024. The Author(s).

Références

Balis F, Green DM, Anderson C et al (2021) Wilms tumor (Nephroblastoma), version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19:945–977. https://doi.org/10.6004/JNCCN.2021.0037
doi: 10.6004/JNCCN.2021.0037 pubmed: 34416707
Cunningham ME, Klug TD, Nuchtern JG et al (2020) Global disparities in Wilms tumor. J Surg Res 247:34–51. https://doi.org/10.1016/J.JSS.2019.10.044
doi: 10.1016/J.JSS.2019.10.044 pubmed: 31810638
Tournade MF, Com-Nougué C, De Kraker J et al (2001) Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms’ tumor in children older than 6 months: results of the Ninth International society of pediatric oncology Wilms’ tumor trial and study. J Clin Oncol 19:488–500. https://doi.org/10.1200/JCO.2001.19.2.488
doi: 10.1200/JCO.2001.19.2.488 pubmed: 11208843
De Kraker J, Graf N, Van Tinteren H et al (2004) Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms’ tumour (SIOP 93–01 trial): a randomised controlled trial. Lancet 364:1229–1235. https://doi.org/10.1016/S0140-6736(04)17139-0
doi: 10.1016/S0140-6736(04)17139-0 pubmed: 15464183
Spreafico F, Pritchard-Jones K, Bergeron C et al (2009) Value and difficulties of a common European strategy for recurrent Wilms’ tumor. Expert Rev Anticancer Ther 9:693–696. https://doi.org/10.1586/ERA.09.45
doi: 10.1586/ERA.09.45 pubmed: 19496704
Ekenze SO, Nwangwu EI, Ezomike UO et al (2019) Continuing barriers to care of Wilms tumor in a low-income country. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.27416
doi: 10.1002/pbc.27416 pubmed: 30152039
Paintsil V, David H, Kambugu J et al (2015) The collaborative Wilms tumour Africa project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa. Eur J Cancer 51:84–91. https://doi.org/10.1016/j.ejca.2014.10.030
doi: 10.1016/j.ejca.2014.10.030 pubmed: 25465189
Kakembo N, Godier-Furnemont A, Nabirye A et al (2019) Barriers to pediatric surgical care in low-income countries: the three delays’ impact in Uganda. J Surg Res 242:193–199. https://doi.org/10.1016/j.jss.2019.03.058
doi: 10.1016/j.jss.2019.03.058 pubmed: 31085367
Mostert S, Arora RS, Arreola M et al (2011) Abandonment of treatment for childhood cancer: position statement of a SIOP PODC working group. Lancet Oncology 12:719–720. https://doi.org/10.1016/S1470
doi: 10.1016/S1470 pubmed: 21719348
Friedrich P, Lam CG, Itriago E et al (2015) Magnitude of treatment abandonment in childhood cancer. PLoS ONE. https://doi.org/10.1371/journal.pone.0135230
doi: 10.1371/journal.pone.0135230 pubmed: 26619190 pmcid: 4664395
Slone JS, Chunda-Liyoka C, Perez M et al (2014) Pediatric malignancies, treatment outcomes and abandonment of pediatric cancer treatment in zambia. PLoS ONE. https://doi.org/10.1371/journal.pone.0089102
doi: 10.1371/journal.pone.0089102 pubmed: 24586527 pmcid: 3931678
Libes J, Oruko O, Abdallah F et al (2015) Risk factors for abandonment of Wilms tumor therapy in Kenya. Pediatr Blood Cancer 62:252–256. https://doi.org/10.1002/pbc.25312
doi: 10.1002/pbc.25312 pubmed: 25382257
Mutyaba I, Wabinga HR, Orem J et al (2019) Presentation and outcomes of childhood cancer patients at Uganda cancer Institute. Glob Pediatr Health. https://doi.org/10.1177/2333794X19849749
doi: 10.1177/2333794X19849749 pubmed: 31205984 pmcid: 6537233
Israels T, Moreira C, Scanlan T et al (2013) SIOP PODC: clinical guidelines for the management of children with Wilms tumour in a low income setting. Pediatr Blood Cancer 60:5–11. https://doi.org/10.1002/pbc.24321
doi: 10.1002/pbc.24321 pubmed: 23015404
Von Elm E, Altman DG, Egger M et al (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLOS Med 4:e296. https://doi.org/10.1371/JOURNAL.PMED.0040296
doi: 10.1371/JOURNAL.PMED.0040296
Israels T, Borgstein E, Pidini D et al (2012) Management of Children With a Wilms Tumor in Malawi, Sub-Saharan Africa. J Pediatr. https://doi.org/10.1097/MPH.0b013e3182580921
doi: 10.1097/MPH.0b013e3182580921
Vasquez L, Diaz R, Chavez S et al (2018) Factors associated with abandonment of therapy by children diagnosed with solid tumors in Peru. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.27007
doi: 10.1002/pbc.27007 pubmed: 29431252
Chagaluka G, Afungchwi GM, Landman L et al (2021) Treatment abandonment: A report from the collaborative African network for childhood cancer care and research—CANCaRe Africa. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.29367
doi: 10.1002/pbc.29367 pubmed: 34549506
Ekenze SO, Okafor OC, Obasi AA et al (2020) Wilms tumor in Africa: a systematic review of management challenges and outcome in two decades (2000–2019). Pediatr Blood Cancer. https://doi.org/10.1002/pbc.28695
doi: 10.1002/pbc.28695 pubmed: 32909662
Ekuk E, Odongo CN, Tibaijuka L et al (2023) One year overall survival of wilms tumor cases and its predictors, among children diagnosed at a teaching hospital in South Western Uganda: a retrospective cohort study. BMC Cancer 23:1–10. https://doi.org/10.1186/S12885-023-10601-2/FIGURES/6
doi: 10.1186/S12885-023-10601-2/FIGURES/6
Mirutse MK, Tolla MT, Memirie ST et al (2022) The magnitude and perceived reasons for childhood cancer treatment abandonment in Ethiopia: from health care providers’ perspective. BMC Health Serv Res. https://doi.org/10.1186/s12913-022-08188-8
doi: 10.1186/s12913-022-08188-8 pubmed: 35941600 pmcid: 9361525
Mansell R, Purssell E (2018) Treatment abandonment in children with cancer in Sub-Saharan Africa: Systematic literature review and meta-analysis. J Adv Nurs 74:800–808
doi: 10.1111/jan.13476 pubmed: 29023923
Chagaluka G, Paintsil V, Renner L et al (2020) Improvement of overall survival in the collaborative Wilms tumour Africa project. Pediatr Blood Cancer 67:e28383. https://doi.org/10.1002/PBC.28383
doi: 10.1002/PBC.28383 pubmed: 32391983
Chakumatha E, Khofi H, Landman L et al (2022) Towards zero percent treatment abandonment of patients with common and curable childhood cancer types in Blantyre Malawi. Pediatr Blood Cancer. https://doi.org/10.1002/pbc.29899
doi: 10.1002/pbc.29899 pubmed: 35869892
Tongaonkar HB, Qureshi SS, Kurkure PA et al (2007) Wilms’ tumor: an update. Indian J Urol 23:458
doi: 10.4103/0970-1591.36722 pubmed: 19718304 pmcid: 2721580
Provenzi VO, Rosa RFM, Rosa RCM et al (2015) Tumor size and prognosis in patients with Wilms tumor. Revista Paulista de Pediatria 33:82. https://doi.org/10.1016/J.RPPED.2014.05.003
doi: 10.1016/J.RPPED.2014.05.003 pubmed: 25623730 pmcid: 4436960
Israëls T, Chirambo C, Caron H et al (2008) The guardians’ perspective on paediatric cancer treatment in Malawi and factors affecting adherence. Pediatr Blood Cancer 51:639–642. https://doi.org/10.1002/PBC.21703
doi: 10.1002/PBC.21703 pubmed: 18668516
Atwiine B, Busingye I, Kyarisiima R et al (2021) “Money was the problem”: Caregivers’ self-reported reasons for abandoning their children’s cancer treatment in southwest Uganda. Pediatr Blood Cancer 68:e29311. https://doi.org/10.1002/PBC.29311
doi: 10.1002/PBC.29311 pubmed: 34459106

Auteurs

Sumayiya Nanteza (S)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Ava Yap (A)

Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA. ava.yap@ucsf.edu.

Caroline Q Stephens (CQ)

Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA.

Joyce Balagadde Kambagu (JB)

Department of Hematology Oncology, Ugandan Cancer Institute, Kampala, Uganda.

Phyllis Kisa (P)

Department of Pediatric Surgery, Makerere University College of Health and Sciences, Kampala, Uganda.

Nasser Kakembo (N)

Department of Pediatric Surgery, Makerere University College of Health and Sciences, Kampala, Uganda.

Geriga Fadil (G)

Department of Hematology Oncology, Ugandan Cancer Institute, Kampala, Uganda.

Stella A Nimanya (SA)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Innocent Okello (I)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Rovine Naluyimbazi (R)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Fiona Mbwali (F)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Peter Kayima (P)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Yasin Ssewanyana (Y)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

David Grabski (D)

Department of Surgery, University of Virginia School of Medicine, Charlottesville, VA, USA.

Bindi Naik-Mathuria (B)

Department of Pediatric Surgery, The University of Texas Medical Branch at Galveston, Webster, TX, USA.

Monica Langer (M)

Department of Pediatric Surgery, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Doruk Ozgediz (D)

Center of Health Equity in Surgery and Anesthesia, University of California San Francisco, 550 16th St, 3rd Floor, San Francisco, CA, 94158, USA.

John Sekabira (J)

Department of Pediatric Surgery, Mulago Hospital, Kampala, Uganda.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH